Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **Ecdysteroid receptor (EcR)** is a member of the nuclear receptor superfamily, functioning as a ligand-activated transcription factor in arthropods[3][4]. It forms a non-covalent heterodimer with the **ultraspiracle protein** (USP; the insect equivalent of mammalian **retinoid X receptor**, RXR), and sometimes, especially in crustaceans, RXR itself[2][3][5][7]. This complex binds specific DNA sequences called ecdysone response elements (ECREs) in the promoters of ecdysteroid-responsive genes[3][5]. Upon binding its natural ligand, **ecdysteroids** (molting hormones such as 20-hydroxyecdysone), EcR undergoes a conformational change that enables transcriptional regulation of genes controlling molting, metamorphosis, reproduction, and other developmental processes[1][7][11]. The EcR-USP (or EcR-RXR) complex is also exploited in biotechnology as an inducible mammalian gene switch[1][9]. In agriculture, synthetic EcR agonists serve as insecticides by disrupting critical developmental signaling, though selectivity and the emergence of resistance present ongoing challenges[10]. EcR is not a direct therapeutic target in humans, but its orthologs, FXR and RXR, participate in related nuclear receptor signaling pathways[3][5]. **Key structural features** include: - Multi-domain architecture (A/B transcription activation domain, C DNA-binding domain, D hinge, E ligand-binding domain, optional F C-terminal extension)[3][4] - Heterodimerization is essential for high affinity ligand binding and DNA interaction[5][8] - Binding pocket in EcR is highly adaptable to ecdysteroid chemistries[1][3] EcR is highly conserved throughout arthropods, with multiple isoforms resulting from alternative splicing and promoter usage, and stage/tissue-specific expression patterns that reflect its central role in hormone-regulated development and physiology.[4][7]
Agonists bind EcR ligand-binding domain, trigger conformational change and activate transcription of ecdysone response genes. Synthetic agonists used as insecticides: bind receptor, disrupt molting/development, leading to death of target arthropod. RNAi knockdown: ecdysone-based control of transgene expression. Biotechnology: use EcR/ligand interaction as a switch for gene expression systems in mammals/plants.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ecdysteroid receptor (EcR).